Point72 Asset Management’s Altimmune ALT Stock Holding History

Point72 Asset Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.48M	Sell	486,884 -178,405	-27%	-$533K	﹤0.01%	2583
2026 Q1	$2.05M	Buy	+665,289	New	+$2.82M	﹤0.01%	2287
2025 Q4	–	Sell	-476,926	Closed	-$1.8M	–	3886
2025 Q3	$1.8M	Buy	+476,926	New	+$1.84M	﹤0.01%	1483
2024 Q2	–	Sell	-7,600	Closed	-$77.4K	–	1822
2024 Q1	$77.4K	Sell	7,600 -1,238,900	-99%	-$12.6M	﹤0.01%	2032
2023 Q4	$14M	Buy	+1,246,500	New	+$5.2M	0.03%	566
2023 Q2	–	Sell	-13,987	Closed	-$59K	–	2133
2023 Q1	$59K	Buy	+13,987	New	+$166K	﹤0.01%	1750
2022 Q3	–	Sell	-609,100	Closed	-$7.13M	–	1385
2022 Q2	$7.13M	Buy	+609,100	New	+$3.76M	0.03%	607
2021 Q3	–	Sell	-1,564,654	Closed	-$15.4M	–	1021
2021 Q2	$15.4M	Buy	+1,564,654	New	+$21.4M	0.07%	346

Other funds holding ALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Point72 Asset Management's ALT Position: Q2 2026 in Review

Point72 Asset Management reduced its Altimmune (ALT) stake by 27% in Q2 2026, selling an estimated $533K and leaving 486,884 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2583.

Point72 Asset Management first reported a position in ALT in Q2 2021 and has held it in 8 quarters since. The position peaked at $15.4M in Q2 2021. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

Point72 Asset Management held 486,884 shares of Altimmune worth $1.48M as of Q2 2026.
Point72 Asset Management sold 178,405 Altimmune shares in Q2 2026, an estimated $533K.
Altimmune made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #2583 holding.
Point72 Asset Management first reported a position in Altimmune in Q2 2021 and has held it in 8 quarters since.
Point72 Asset Management's Altimmune position peaked at $15.4M in Q2 2021.
211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.